stockrow
Monday 9 November 2026
Export BJDX’s income statement to Excel — free account
Bluejay Diagnostics, Inc.
BJDXBluejay Diagnostics, Inc.’s revenue for fiscal 2022 (year ended December 2022) was $249,000.00.
- EPS
- +80.1%
- Free cash flow
- +20.1%
Quarter to June 2026, against a year earlier
2.35
0.16
+7.31%
Follow BJDX
Alert me
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | 0.00 | — | — | — |
P/S ratio |
— | — | — | — | 0.00 | — | — | — |
Altman Z-Score |
— | — | — | — | (0.90) | — | — | — |
P/FCF ratio |
— | — | — | — | 0.00 | — | — | — |
Altman Z″-Score (non-manufacturers) |
— | — | — | — | 2.32 | — | — | — |
P/Operating CF |
— | — | — | — | (2.54) | — | — | — |
P/B ratio |
— | — | — | — | 0.65 | — | — | — |
Price to Tangible BV |
— | — | — | — | 0.65 | — | — | — |
EV/Sales |
— | — | — | — | 0.00 | — | — | — |
EV/EBITDA |
— | — | — | — | 0.00 | — | — | — |
EV/Operating CF |
— | — | — | — | (0.28) | — | — | — |
EV/FCF |
— | — | — | — | (0.24) | — | — | — |
Quick Ratio |
— | 0.17 | 0.49 | 29.89 | 6.17 | 1.25 | 5.31 | 4.61 |
Current Ratio |
— | 0.52 | 0.57 | 32.42 | 7.19 | 1.82 | 6.05 | 4.88 |
Net Debt/EBITDA |
— | (0.48) | 0.88 | 6.18 | 1.12 | 0.23 | 0.62 | 0.76 |
Debt/Assets |
0.00% | 87.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | (0.27) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 2.06 | 0.44 | 1.25 | 0.83 | 0.84 | 0.37 | 0.88 |
Capex/Depreciation |
— | (0.04) | 0.00 | (0.16) | (3.91) | (0.90) | (1.54) | (1.02) |
Interest Coverage |
— | (31.19) | — | (8.79) | — | — | (8.71) | (8,691.25) |
| — | 22.97% | 32.45% | (43.13%) | (58.25%) | (137.90%) | (485.63%) | (117.02%) | |
| — | (178.90%) | (95.18%) | (30.96%) | (53.83%) | (108.25%) | (363.37%) | (99.42%) | |
ROIC |
— | 0.00% | 0.00% | (151.35%) | (408.30%) | (939.02%) | (313.88%) | (536.23%) |
Return on Tangible Assets |
— | (241.12%) | 353.03% | (17.13%) | (81.69%) | (363.92%) | (373.81%) | (116.49%) |
Average Days of Receivables |
— | 0.00 | — | — | 0.00 | — | — | — |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 1,667.55% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 2,094.18% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | 173.90% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | — | — | — | 1.31 | — | — | — |
Graham Number |
— | — | — | — | 0.00 | — | — | — |
Earnings Yield |
— | — | — | — | (120.61%) | — | — | — |
Free Cash Flow Yield |
— | — | — | — | (119.50%) | — | — | — |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 415.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | (16,901.00) | (5,087.00) | (16,396.20) | (12,902.67) | (12,132.65) | (170.76) | (13.48) |
Capex per Share |
— | (60.00) | 0.00 | (89.74) | (1,998.83) | (1,027.65) | (6.70) | (0.39) |
Free Cash Flow per Share |
— | (16,961.00) | (5,087.00) | (16,485.94) | (14,901.50) | (13,160.31) | (177.46) | (13.87) |
Cash per Share |
— | 960.00 | 9,124.00 | 71,519.54 | 16,858.33 | 3,222.91 | 93.93 | 11.50 |
Shareholders Equity per Share |
— | (29,324.00) | (42,062.00) | 76,527.99 | 19,235.50 | 4,224.44 | 125.10 | 13.31 |
Interest Debt per Share |
— | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (29,324.00) | (42,062.00) | 76,527.99 | 19,235.50 | 4,224.44 | 125.10 | 13.31 |
Free Cash Flow |
— | (1.70) | (0.51) | (4.39) | (8.94) | (9.02) | (8.13) | (6.23) |
Working Capital |
— | (0.28) | (0.79) | 20.02 | 10.15 | 1.45 | 4.09 | 4.34 |
Capital Expenditures |
— | (0.01) | — | (0.02) | (1.20) | (0.70) | (0.31) | (0.17) |
Net Current Asset Value |
— | (3.55) | (4.67) | 20.02 | 9.81 | 1.25 | 3.97 | 4.32 |
EV/EBIT |
— | — | — | — | 0.00 | — | — | — |
Capex to Sales |
— | 0.00 | — | 0.00 | 4.82 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
— | — | — | — | 0.00 | — | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | 0.23 | 0.34 | 0.43 | 0.25 | 0.61 | 0.13 | 0.11 |
Cash ROIC |
— | 83.47% | 15.44% | (11.14%) | (41.29%) | (176.71%) | (81.02%) | (55.90%) |
Accounts Receivable Turnover |
— | — | — | — | 0.00 | — | — | — |
Accounts Payable Turnover |
— | 0.71 | 0.78 | 0.43 | 0.43 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | 1.37 | 1.51 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
— | 74.28 | 871.58 | 741.02 | 1,159.76 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 315.23 | 197.15 | 0.00 | 0.00 | — | — | — |
Average Payables |
— | 0.20 | 0.20 | 0.34 | 0.47 | 0.56 | 0.32 | 0.18 |
Average Inventory |
— | 0.10 | 0.10 | — | — | — | — | — |
Average Assets |
— | 0.46 | 1.22 | 11.27 | 17.27 | 9.19 | 5.76 | 6.89 |
Average Common Equity |
— | (3.57) | (3.57) | 8.09 | 15.96 | 7.22 | 4.31 | 5.85 |
Columns are period end dates · fundamentals updated 26 Oct 2026